Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-25

FDA Approved: FOSPHENYTOIN SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for fosphenytoin sodium from Hikma Pharmaceuticals USA Inc., confirming continued marketing of the generic under the app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosphenytoin Sodium (fosphenytoin sodium)

Snippet

SUPPL AP for FOSPHENYTOIN SODIUM (FOSPHENYTOIN SODIUM)